Australia markets closed

Allergy Therapeutics plc (AGY.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
5.80+0.30 (+5.45%)
As of 09:35AM BST. Market open.
Show:
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
53,258
59,587
72,768
84,331
78,204
Cost of revenue
25,276
26,342
23,262
22,106
20,201
Gross profit
27,982
33,245
49,506
62,225
58,003
Operating expenses
Research development
23,009
20,121
15,659
12,887
5,848
Selling general and administrative
45,144
48,884
46,832
45,874
44,480
Total operating expenses
66,819
68,149
61,751
58,194
49,694
Operating income or loss
-38,837
-34,904
-12,245
4,031
8,309
Interest expense
5,232
2,441
669
491
504
Income before tax
-48,482
-41,766
-12,657
3,657
8,071
Income tax expense
1,734
1,305
1,119
771
1,013
Income from continuing operations
-50,216
-43,071
-13,776
2,886
7,058
Net income
-50,216
-43,071
-13,776
2,886
7,058
Net income available to common shareholders
-50,216
-43,071
-13,776
2,886
7,058
Basic EPS
-0.01
-0.08
-0.02
0.00
0.01
Diluted EPS
-0.01
-0.08
-0.02
0.00
0.01
Basic average shares
641,444
670,355
642,990
639,190
636,169
Diluted average shares
679,050
670,355
684,076
676,658
673,492